COVID-19検査キットの世界市場規模：サンプルタイプ別、検査タイプ別、製品タイプ別、最終用途別、地域別・予測

COVID-19検査キットの市場規模と予測

COVID-19検査キット市場規模は、2024年に73億1,320万米ドルと評価され、2026～2032年に13.06%のCAGRで成長し、2032年には26億6,880万米ドルに達すると予測されています。

COVID-19検出キットは、試験管内でSARS-CoV-2の診断と同定に使用されます。これらのキットは数分から数時間で迅速な結果をもたらし、適切な患者ケアを支援します。

患者ケアの向上、継続的な技術の進歩、COVID-19検出キットに対する需要の増加が、予測期間中の市場拡大の原動力となると思われます。

ほとんどの国ではほとんどの人が予防接種を受けており、COVID-19の新規感染者数は減少しています。このような要因は、今後数年間の市場成長の妨げになると思われます。

大半の国では、ドライブスルーやウォークスルーの検査センターを設置することで、検査場所の数を増やしています。

これらの検査センターは待ち時間を短縮し、ヘルスケア従事者の感染リスクを低下させます。コロナウイルスの同定については、自宅でのサンプル採取技術が、より安全な選択肢として浮上してきました。

これらの要因が交差することで、供給不足と検査場所の制限という困難に取り組んでいます。

COVID-19検査キットの世界市場力学

世界のCOVID-19検査キット市場を形成している主な市場力学は以下の通りです：

主な促進要因

世界的パンデミック：COVID-19の急速な蔓延により、症例を効果的に特定、隔離、治療するための大量検査の必要性が高まりました。

政府の取り組み：世界の多くの政府が定期的な検査を義務付け、ヘルスケアシステムや業界全体の検査キット需要を促進しました。

技術の進歩：世界保健機関（WHO）によると、2024年現在、世界中で100種類以上のSARS-CoV-2亜種が確認されています。米国疾病予防管理センター（CDC）の報告によると、オミクロン変種が出現した2021年12月、米国では1日平均160万件の検査が実施され、2021年10月から300％増加しました。RT-PCR、迅速抗原、抗体検査などの検査方法の革新により、精度が向上し、検査時間が短縮されました。

意識の高まり：早期発見と予防に対する意識の高まりにより、一般市民が利用しやすい検査キットの必要性が高まりました。

企業規制と出張規制：旅行、職場、イベントでの検査が義務化され、検査キットの需要が高まりました。

主な課題

サプライチェーンの混乱：原材料の世界的な不足と製造のボトルネックにより、検査キットの生産と流通に遅れが生じました。

精度と信頼性の問題：一部の迅速検査は、ゴールドスタンダードのRT-PCR検査と比較して精度が低いという批判に直面しました。

進化するウイルス株：COVID-19の新しい変異型の出現により、変異に対する検査精度と有効性についての懸念が生じました。

高い検査費用：頻繁な検査、特に低所得地域では、大規模で継続的な検査を行うには経済的な課題がありました。

競合と過剰生産：市場に参入する企業が急増したため、価格の変動や品質管理への懸念が生じました。

主な動向

家庭用検査キット：自宅で簡便に検査できる自己検査キットの需要が大幅に増加しました。

迅速検査：迅速抗原検査は、数分以内に結果が得られるため、旅行やイベントでのその場での検査に理想的であるとして人気を集めました。

ポイント・オブ・ケア診断薬：診療所やポイント・オブ・ケアで使用するために設計された検査キットは、複雑な検査機器を必要とせずに迅速な診断を可能にしました。

デジタルプラットフォームとの統合：多くの検査キットは、モバイルアプリやデジタルプラットフォームと統合され、結果の追跡、確認、報告が可能です。

費用対効果の高いソリューションへの注力：新興諸国や十分なサービスを受けていない地域でも利用できるよう、低価格の検査ソリューションを開発する企業が増えています。

目次

第1章 COVID-19検査キットの世界市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 COVID-19検査キットの世界市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 COVID-19検査キットの世界市場：サンプルタイプ別

• 概要
• 鼻咽頭（NP）スワブ
• 口腔咽頭（OP）スワブ
• 鼻腔スワブ
• その他

第6章 COVID-19検査キットの世界市場：検査タイプ別

• 概要
• 分子（PCR）検査
• 抗原ベースの検査
• 抗体（血清）検査
• その他

第7章 COVID-19検査キットの世界市場：最終用途別

• 概要
• 研究所
• 病院
• 診断センターおよびクリニック
• 研究機関

第8章 COVID-19検査キットの世界市場：製品タイプ別

• 概要
• 試薬・キット
• 検査機器
• サービス

第9章 COVID-19検査キットの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 世界のCOVID-19検査キット市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な開発戦略

第11章 企業プロファイル

• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Thermo Fisher Scientific, Inc.
• PerkinElmer, Inc.
• drop, Inc.
• Veredus Laboratories
• Altona Diagnostics GmbH（ADT Biotech Sdn Bhd）
• BioFire Diagnostics
• Co-Diagnostics, Inc
• GenMark Diagnostics, Inc.
• BGI
• Qiagen
• Randox Laboratories Ltd
• SD Biosensor

第12章 付録

• 関連レポート

COVID-19 Testing Kits Market Size And Forecast

COVID-19 Testing Kits Market size was valued at USD 7313.2 Million in 2024 and is projected to reach USD 2668.8 Million by 2032, growing at a CAGR of 13.06% from 2026 to 2032.

The COVID-19 detection kits are used to diagnose and identify SARS-CoV-2 in vitro. These kits deliver quicker results in a matter of minutes or hours, assisting in proper patient care.

Improved patient care, ongoing technical advancements, and increased demand for COVID-19 detection kits will drive market expansion over the forecast period.

Most people in most countries are vaccinated, and the number of new COVID-19 infections is declining. Such a factor will hinder market growth in the approaching years.

The majority of countries have increased the number of testing locations by establishing drive-through and walk-through testing centers.

These testing centers shorten wait times and lower the risk of infection among healthcare workers. For the identification of the coronavirus, at-home sample collection techniques have emerged as a substantially safer option.

The intersection of these factors tackles the difficulties of a supply shortage and a limited amount of testing locations.

The majority of countries have increased the number of testing locations by establishing drive-through and walk-through testing centers.

These testing centers shorten wait times and lower the risk of infection among healthcare workers. For the identification of the coronavirus, at-home sample collection techniques have emerged as a substantially safer option.

The intersection of these factors tackles the difficulties of a supply shortage and a limited number of testing locations.

Global Covid-19 Testing Kits Market Dynamics

The key market dynamics that are shaping the global COVID-19 testing kits market include:

Key Drivers

Global Pandemic: The rapid spread of COVID-19 increased the need for mass testing to identify, isolate, and treat cases effectively.

Government Initiatives: Many governments worldwide mandated regular testing, driving demand for testing kits across healthcare systems and industries.

Technological Advancements: According to the World Health Organization (WHO), as of 2024, over 100 SARS-CoV-2 variants have been identified globally. The Centers for Disease Control and Prevention (CDC) reports that during the emergence of the Omicron variant, the U.S. conducted an average of 1.6 million tests per day in December 2021, a 300% increase from October 2021. Innovations in testing methods like RT-PCR, rapid antigen, and antibody tests improved accuracy and reduced testing time.

Rising Awareness: Increased awareness about early detection and prevention fueled the need for accessible testing kits for the general population.

Corporate and Travel Regulations: Mandatory testing for travel, workplaces, and events sustained demand for testing kits.

Key Challenges

Supply Chain Disruptions: Global shortages of raw materials and manufacturing bottlenecks created delays in test kit production and distribution.

Accuracy and Reliability Issues: Some rapid tests faced criticism over lower accuracy rates compared to gold-standard RT-PCR tests.

Evolving Virus Strains: The emergence of new COVID-19 variants led to concerns about test accuracy and effectiveness against mutations.

High Cost of Testing: Frequent testing, especially in low-income regions, posed affordability challenges for large-scale, continuous testing.

Competition and Overproduction: The rapid influx of players into the market caused price fluctuations and concerns about quality control.

Key Trends

At-Home Testing Kits: There was a significant rise in demand for self-testing kits, enabling convenient testing from home.

Rapid Testing: Rapid antigen tests gained popularity due to their ability to deliver results within minutes, ideal for on-the-spot testing in travel and events.

Point-of-Care Diagnostics: Testing kits designed for use in clinics and at point-of-care settings enabled quicker diagnostics without needing complex lab equipment.

Integration with Digital Platforms: Many testing kits are integrated with mobile apps and digital platforms for result tracking, verification, and reporting.

Focus on Cost-Effective Solutions: Companies increasingly developed low-cost testing solutions to ensure accessibility in developing countries and underserved regions.

Global Covid-19 Testing Kits Market Regional Analysis

Here is a more detailed regional analysis of the global COVID-19 testing kits market:

Asia Pacific

The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions.

Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests.

The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Collaborations between governments, healthcare organizations, and private companies have facilitated research and development efforts to enhance the accuracy and efficiency of testing solutions.

Increased public awareness about the importance of testing and monitoring COVID-19 infections has further propelled market growth.

As vaccination rates rise and the focus shifts toward managing the pandemic, the demand for COVID-19 testing kits is expected to evolve, with an emphasis on at-home testing and innovative technologies such as digital health platforms.

The Asia Pacific region is poised to play a crucial role in shaping the future of the COVID-19 testing kits market through continued innovation and collaboration.

North America

North America, is anticipated to witness the fastest growth in the Global COVID-19 Testing Kits Market during the forecast period driven by the urgent need for widespread testing during the pandemic.

The U.S. Department of Health and Human Services invested $785 million in 2024 to improve COVID-19 testing access for vulnerable and high-risk populations.

According to a survey by the College of American Pathologists, 72% of medical laboratories have expanded their molecular testing capabilities since 2020, with COVID-19 testing representing an average of 30% of their molecular diagnostics workload.

The U.S. Bureau of Labor Statistics projects a 7% growth in clinical laboratory technologist and technician jobs from 2021 to 2032, partly driven by continued COVID-19 testing demands.

The United States and Canada implemented aggressive testing strategies to manage the virus's spread, leading to increased demand for various testing kits, including PCR, rapid antigen, and antibody tests.

The U.S. Food and Drug Administration (FDA) played a crucial role in accelerating the approval process for testing kits, allowing manufacturers to bring their products to market quickly.

This expedited regulatory environment fostered innovation and competition among companies, resulting in a diverse range of testing solutions that cater to different needs, from laboratory-based tests to at-home testing kits.

Partnerships between public health agencies, research institutions, and private companies have enhanced the development and distribution of testing kits.

The region has also witnessed significant investments in research and development, aimed at improving the accuracy and efficiency of COVID-19 testing methods.

Global COVID-19 Testing Kits Market: Segmentation Analysis

The Global COVID-19 Testing Kits Market is Segmented based on Sample Type, Test Type, Product Type, End-Use, and Geography.

COVID-19 Testing Kits Market, By Sample Type

• Nasopharyngeal (NP) Swab
• Oropharyngeal (OP) Swab
• Nasal Swab

Based on sample type, the Global COVID-19 Testing Kits Market is segmented into Nasopharyngeal (NP) Swabs, Oropharyngeal (OP) Swabs, and Nasal Swabs. The Nasopharyngeal (NP) Swab segment holds a significant share in the market owing to its high accuracy and widespread use in detecting viral infections. The Oropharyngeal (OP) Swab and Nasal Swab segments are also vital in diagnostic processes, providing alternatives in sample collection methods to accommodate patient comfort and clinical needs.

COVID-19 Testing Kits Market, By Test Type

• Molecular (PCR) Testing
• Antigen-based Testing
• Antibody (Serology) Testing

Based on test type, the Global COVID-19 Testing Kits Market is segmented into Molecular (PCR) Testing, Antigen-based Testing, and Antibody (Serology) Testing. The Molecular (PCR) Testing segment dominates the Global COVID-19 Testing Kits Market owing to its high accuracy in detecting active infections by identifying the virus's genetic material.

COVID-19 Testing Kits Market, By Product Type

• Reagents & Kits
• Instruments
• Service

Based on product type, the Global COVID-19 Testing Kits Market is segmented into Reagents & Kits, Instruments, and Services. The Reagents & Kits segment holds a significant share of the Global COVID-19 Testing Kits Market, driven by the need for mass testing to curb the spread of the virus.

COVID-19 Testing Kits Market, By End-Use

• Laboratories, Hospitals
• Diagnostic Centers and Clinics,
• Research Institutes

Based on end-use, the global COVID-19 testing kits market is segmented into Laboratories, Hospitals, Diagnostic Centers and Clinics, and Research Institutes. The Laboratories and Hospitals segment dominates in the Global COVID-19 Testing Kits Market owing to the large-scale testing and treatment of COVID-19 patients in medical facilities.

COVID-19 Testing Kits Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on geography, the global COVID-19 testing kits market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region has experienced significant growth in the Global COVID-19 Testing Kits Market, driven by rising infection rates and the urgent need for rapid and accurate testing solutions. Governments across countries such as India, China, Japan, and Australia have implemented extensive testing protocols to contain the virus's spread, resulting in increased demand for various types of testing kits, including PCR, rapid antigen, and antibody tests. The region's robust manufacturing capabilities have allowed local companies to scale up production and meet the surging demand for testing kits.

Key Players

The "Global COVID-19 Testing Kits Market" study report provides valuable insight with an emphasis on the global market. The major players in the market are Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., 1drop, Inc., Veredus Laboratories, Altona Diagnostics GmbH (ADT Biotech Sdn Bhd), BGI, Cepheid BioFire Diagnostics, Co-Diagnostics, Inc, GenMark Diagnostics, Inc., Qiagen, Randox Laboratories Ltd, SD Biosensor.

• This section offers in-depth analysis through a company overview, position analysis, the regional and industrial footprint of the company, and the ACE matrix for insightful competitive analysis. The section also provides an exhaustive analysis of the financial performances of mentioned players in the given market.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Covid-19 Testing Kits Market Key Developments

• In July 2020, Mylab Discovery Solutions made the Pathocatch COVID-19 antigen fast testing kit available, developed in collaboration with LabCare Diagnostics, a Gujarat-based company. As a result of this progress, the company improved its market position.
• In February 2021, Thermo Fisher Scientific announced the launch of the CE-IVD-Marked TaqPath COVID-19 HT Kit, a COVID-19 diagnostic assay compatible with the Amplitude platform, designed for high throughput and reliable, accurate testing. This product launch aided the corporation in gaining market share.

TABLE OF CONTENTS

1 INTRODUCTION TO THE GLOBAL COVID19 TESTING KITS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COVID19 TESTING KITS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porter Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COVID19 TESTING KITS MARKET, BY SAMPLE TYPE

• 5.1 Overview
• 5.2 Nasopharyngeal (NP) Swab
• 5.3 Oropharyngeal (OP) Swab
• 5.4 Nasal Swab
• 5.5 Others

6 GLOBAL COVID19 TESTING KITS MARKET, BY TEST TYPE

• 6.1 Overview
• 6.2 Molecular (PCR) Testing
• 6.3 Antigen-based Testing
• 6.4 Antibody (Serology) Testing
• 6.5 Others

7 GLOBAL COVID19 TESTING KITS MARKET, BY END-USE

• 7.1 Overview
• 7.2 Laboratories
• 7.3 Hospitals
• 7.4 Diagnostic Centers and Clinics
• 7.5 Research Institutes

8 GLOBAL COVID19 TESTING KITS MARKET, BY PRODUCT TYPE

• 8.1 Overview
• 8.2 Reagents & Kits
• 8.3 Instruments
• 8.4 Service

9 GLOBAL COVID19 TESTING KITS MARKET, BY GEOGRAPHY

• 9.1 Overview
• 9.2 North America
  • 9.2.1 The U.S.
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 The U.K.
  • 9.3.3 France
  • 9.3.4 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Rest of Asia Pacific
• 9.5 Rest of the World
  • 9.5.1 Latin America
  • 9.5.2 Middle East and Africa

10 GLOBAL COVID19 TESTING KITS MARKET COMPETITIVE LANDSCAPE

• 10.1 Overview
• 10.2 Company Market Ranking
• 10.3 Key Development Strategies

11 COMPANY PROFILES

• 11.1 F. Hoffmann-La Roche AG
  • 11.1.1 Overview
  • 11.1.2 Financial Performance
  • 11.1.3 Product Outlook
  • 11.1.4 Key Developments
• 11.2 Abbott Laboratories
  • 11.2.1 Overview
  • 11.2.2 Financial Performance
  • 11.2.3 Product Outlook
  • 11.2.4 Key Developments
• 11.3 Thermo Fisher Scientific, Inc.
  • 11.3.1 Overview
  • 11.3.2 Financial Performance
  • 11.3.3 Product Outlook
  • 11.3.4 Key Developments
• 11.4 PerkinElmer, Inc.
  • 11.4.1 Overview
  • 11.4.2 Financial Performance
  • 11.4.3 Product Outlook
  • 11.4.4 Key Developments
• 11.51drop, Inc.
  • 11.5.1 Overview
  • 11.5.2 Financial Performance
  • 11.5.3 Product Outlook
  • 11.5.4 Key Developments
• 11.6 Veredus Laboratories
  • 11.6.1 Overview
  • 11.6.2 Financial Performance
  • 11.6.3 Product Outlook
  • 11.6.4 Key Developments
• 11.7 Altona Diagnostics GmbH (ADT Biotech Sdn Bhd)
  • 11.7.1 Overview
  • 11.7.2 Financial Performance
  • 11.7.3 Product Outlook
  • 11.7.4 Key Developments
• 11.8 BioFire Diagnostics
  • 11.8.1 Overview
  • 11.8.2 Financial Performance
  • 11.8.3 Product Outlook
  • 11.8.4 Key Developments
• 11.9 Co-Diagnostics, Inc
  • 11.9.1 Overview
  • 11.9.2 Financial Performance
  • 11.9.3 Product Outlook
  • 11.9.4 Key Developments
• 11.10 GenMark Diagnostics, Inc.
  • 11.10.1 Overview
  • 11.10.2 Financial Performance
  • 11.10.3 Product Outlook
  • 11.10.4 Key Developments
• 11.11 BGI
  • 11.11.1 Overview
  • 11.11.2 Financial Performance
  • 11.11.3 Product Outlook
  • 11.11.4 Key Developments
• 11.12 Qiagen
  • 11.12.1 Overview
  • 11.12.2 Financial Performance
  • 11.12.3 Product Outlook
  • 11.12.4 Key Developments
• 11.13 Randox Laboratories Ltd
  • 11.13.1 Overview
  • 11.13.2 Financial Performance
  • 11.13.3 Product Outlook
  • 11.13.4 Key Developments
• 11.14 SD Biosensor
  • 11.14.1 Overview
  • 11.14.2 Financial Performance
  • 11.14.3 Product Outlook
  • 11.14.4 Key Developments

12 Appendix

• 12.1.1 Related Reports